Formulations of low oil content comprising diphenylmethane derivatives

A pharmaceutical preparation and preparation technology, applied in the field of preparations containing diphenylmethane derivatives with low oil content, can solve the problem of whitening skin toxicology acceptability, skin tolerance and/or stability without predictable relationship, etc. problem, to achieve high bioavailability, effective activity, improve skin whitening activity

Inactive Publication Date: 2009-02-11
SYMRISE GMBH & CO KG
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, there was no predictable relationship between the skin lightening and hair bleaching effects, toxicological acceptability, skin tolerance and / or stability of the potential active compounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Formulations of low oil content comprising diphenylmethane derivatives
  • Formulations of low oil content comprising diphenylmethane derivatives
  • Formulations of low oil content comprising diphenylmethane derivatives

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0342] In Vivo Study of Skin Lightening Effect of Styryl Resorcinol (Formula 3)

[0343] From the following studies it was found that the diphenylmethane derivative of formula 1 has a particularly good skin whitening effect when it is applied to the skin in a formulation with a low oil phase content.

[0344] Asian volunteers (Fitzpatrick skin, type III) were treated with emulsions A-F with a size of 1.5 cm on the back 2 skin for 7 days, 2 times a day. The volunteers were irradiated with UV-A light on day 8 (4 different doses produced weak, mild, moderate and strong pigmentation, respectively). Treatment with Emulsions A-F was repeated for another 14 days. Skin color was measured visually on days 8 and 21 (L * value).

example 1

[0347] Preparation instructions :

[0348] Separately heat phases A and B to about 80°C. Add Phase B to Phase A using an Ultra-Turrax mixer and emulsify. The emulsion was stirred with a paddle stirrer until cooled, the stirring speed decreased as the temperature decreased. The pH of the emulsion was adjusted to about 5.6-5.8 with sodium hydroxide solution.

[0349] Formulation II :

[0350] The formulation is very high in water and low in lipids.

[0351] Furthermore, no customary emulsifiers but surface-modified polymers are used here. (=hydrogel cream preparation)

[0352]

Substances used

INCI name

emulsion

D. emulsion

E. emulsion

f A.

Neo Pcl wssl.N

Trideceth-9

(Trideceth-9)

PEG-5

Ethylhexanoate 1.5

1.5

1.5

...

Embodiment 2

[0360] Example 2 : Study on the antioxidant capacity of styryl resorcinol (Formula 3; CARN 85-27-8; 4-(1-phenylethyl)-1,3-dihydroxybenzene) by ABTS method

[0361] Phenolic compounds generally have very good antioxidant activity. To test the degree of antioxidant potential also possessed by styryl resorcinol (Formula 3; CARN 85-27-8; 4-(1-phenylethyl)-1,3-dihydroxybenzene), the ABTS method was used to study said substance. For qualitative and quantitative evaluation of the antioxidant potential, its activity was compared with that of α-tocopherol, a highly active and versatile antioxidant.

[0362] Description of the ABTS method experiment

[0363] ABTS method is a cell-free in vitro test for evaluating antioxidant capacity (document: Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C.1999. "Antioxidant activity applying an improved ABTS radical cation decolorization assay" ; Free Radic. Biol. Med. 26:1231-7). This method exploits the inherent coloratio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
spfaaaaaaaaaa
Login to view more

Abstract

The present invention relates to specific (cosmetic) formulations for improving the bioavailability and activity of skin- or hair-lightening or senile keratosis-reducing diphenylmethane derivatives (tyrosinase inhibitors) of the following formula (1).

Description

technical field [0001] The present invention relates to specific (cosmetic) preparations for enhancing the activity of diphenylmethane derivatives of the formula 1 (tyrosine bioavailability and activity of enzyme inhibitors): [0002] [0003] in [0004] R1 is [0005] -hydrogen, [0006] -methyl, [0007] - linear or branched saturated or unsaturated alkyl groups having 2 to 4 carbon atoms, [0008] -OH or [0009] -halogen, [0010] R2 is [0011] -hydrogen, [0012] - methyl or [0013] - linear or branched saturated or unsaturated alkyl groups having 2 to 5 carbon atoms, [0014] R3 is [0015] - methyl or [0016] - linear or branched saturated or unsaturated alkyl groups having 2 to 5 carbon atoms, [0017] as well as [0018] R4 and R5 independently of each other are [0019] -hydrogen, [0020] -methyl, [0021] - linear or branched saturated or unsaturated alkyl groups having 2 to 5 carbon atoms, [0022] -OH or [0023] -halogen. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K8/34A61Q5/08A61Q19/02A61Q19/08
CPCA61K8/347A61Q5/08A61K2800/782A61Q19/02A61P17/12
Inventor 加布里埃莱·菲尔哈伯格哈德·施毛斯扎比内·朗格卡林·沙佩尔
Owner SYMRISE GMBH & CO KG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products